Harvard Bioscience Inc

HBIONASDAQUSD
6.13 USD
0.22 (3.72%)AT CLOSE (11:59 AM EDT)
6.08
0.05 (0.82%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
6.08
0.05 (0.82%)
🔴Market: CLOSED
Open?$5.88
High?$6.25
Low?$5.74
Prev. Close?$5.91
Volume?43.8K
Avg. Volume?193.4K
VWAP?$6.09
Rel. Volume?0.23x
Bid / Ask
Bid?$5.30 × 1.0K
Ask?$6.14 × 100
Spread?$0.84
Midpoint?$5.72
Valuation & Ratios
Market Cap?27.4M
Shares Out?4.5M
Float?34.0M
Float %?76.0%
P/E Ratio?N/A
P/B Ratio?2.00
EPS?-$12.68
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.20Strong
Quick Ratio?1.25Adequate
Cash Ratio?0.39Low
Debt/Equity?2.61High
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
2.00CHEAP
P/S?
0.32CHEAP
P/FCF?
5.0CHEAP
EV/EBITDA?
10.3CHEAP
EV/Sales?
0.63CHEAP
Returns & Efficiency
ROE?
-412.8%WEAK
ROA?
-70.8%WEAK
Cash Flow & Enterprise
FCF?$5.5M
Enterprise Value?$54.7M
Related Companies
Loading...
News
Profile
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Employees
339
Market Cap
26.4M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2000-12-07
Address
84 OCTOBER HILL RD
HOLLISTON, MA 01746
Phone: (508) 893-8999